JPRN-UMIN000027412
Recruiting
未知
Efficacy of Positron Emission Mammography in decision of the surgery method - Efficacy of Positron Emission Mammography in decision of the surgery method
Aichi cancer center hospital0 sites190 target enrollmentMay 19, 2017
Conditionsbreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- Aichi cancer center hospital
- Enrollment
- 190
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients who are not suitable for surgery by MMG, US, MRI patients who plan preoperative chemotherapy patient with the serious allergic disease Patients with pregnancy or breastfeeding Patients with difficult of taking PEM
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Efficacy of Positron Emission Mammography in evaluating clinical response after preoperative chemotherapyBreast CancerJPRN-UMIN000027374Aichi Cancer Center50
Completed
Not Applicable
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRIBreast CancerNCT02770586Mayo Clinic50
Terminated
Not Applicable
Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) SystemBreast CancerNCT02426489Weinberg Medical Physics LLC1
Completed
Not Applicable
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast CancerBreast CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT01892540Case Comprehensive Cancer Center43
Recruiting
Phase 2
Brentuximab Vedotin in combination with donor lymphocyte infusions for Hodgkin lymphoma relapsing or persisting after allogeneic stem cell transplantatioACTRN12619000581167Melbourne Health10